Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis

BACKGROUND: The World Health Organization recommends protease inhibitor (PI)-based antiretroviral therapy (ART) as second-line and third-line regimens in pregnant women living with HIV (WLHIV). US, European, and UK guidelines include PI-based ART as first-line regimens, but advise against the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowdell, Imogen, Beck, Katharina, Portwood, Clara, Sexton, Harriet, Kumarendran, Mary, Brandon, Zoe, Kirtley, Shona, Hemelaar, Joris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061981/
https://www.ncbi.nlm.nih.gov/pubmed/35521067
http://dx.doi.org/10.1016/j.eclinm.2022.101368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061981/
https://www.ncbi.nlm.nih.gov/pubmed/35521067
http://dx.doi.org/10.1016/j.eclinm.2022.101368

Ejemplares similares